FDA Approves Keppra(R) Intravenous Formulation
Thu, 03 Aug 2006 06:00 AM EST
... Today UCB announcedthat the U.S. Food and Drug Administration (FDA) has approved Keppra(R)(levetiracetam) injection 500mg/5mL (100mg/mL) for use as adjunctivetherapy in the treatment of partial-onset seizures in adults with epilepsy. [click link for full article] ...
Related Topics
- Levetiracetam
- Levetiracetam Oral Solution
- Tacrolimus ointment
- Mammography
- Minocycline Injection
- Conjugated Estrogens Injection
- Carcinogens
- Cytomegalovirus Immune Globulin Intravenous Injection
- Bexarotene Oral
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Hepatitis B Vaccine
- Thalidomide
- Drotrecogin alfa
- Chelation therapy
- Ethacrynic Acid
- Zoledronic Acid for Injection
- Dantrolene
- Food Labeling
- Immune Globulin Intravenous Injection

Not Signed In -


